Drug intelligence / Profile preview

Collygen BioDec

Development stage: Preclinical
Lead developer: Tiss'You
Modality: Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems
Administration: Surgical Implantation

Overview

Collygen BioDec is a collagen-based cell-programming scaffold developed by Tiss' You for active tissue regeneration. Classified as a medical device, it serves as a structural and signaling matrix designed to modulate or 'program' cells in situ at the site of injury. By providing a biocompatible environment that mimics the natural extracellular matrix, it facilitates the recruitment and activation of cells necessary for tissue repair. It is intended for surgical implantation to treat various tissue defects and promote functional recovery.

Brand names: Collygen BioDec

Beyond the preview

Go deeper on Collygen BioDec.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collygen BioDec.

Explore the full profile